Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
33 hedge funds and large institutions have $22M invested in Global Cord Blood Corporation in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
6% less funds holding
Funds holding: 35 → 33 (-2)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
77% less capital invested
Capital invested by funds: $96.3M → $22M (-$74.3M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$550K |
| 2 |
Morgan Stanley
New York
|
+$301K |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$134K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$45K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$33.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$1.18M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$685K |
| 3 |
AC
Athos Capital
Hong Kong
|
-$299K |
| 4 |
Millennium Management
New York
|
-$177K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$132K |
CO Hedge Fund Activity: Q1 2020 in Review
33 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2020, worth a combined $22M — down 77% from $96.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CO positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 12 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $550K. The largest seller was Man Group, cutting an estimated $1.18M.
- 33 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2020, down from 35 in Q4 2019.
- Funds reported $22M of Global Cord Blood Corporation stock for Q1 2020, down 77% quarter-over-quarter.
- 4 funds opened new Global Cord Blood Corporation positions in Q1 2020 and 3 closed out, a net change of +1 holder.
- The largest Global Cord Blood Corporation buyer in Q1 2020 was Renaissance Technologies, an estimated $550K added.
- The largest Global Cord Blood Corporation seller in Q1 2020 was Man Group, an estimated $1.18M sold.
Based on aggregated 13F filings for Q1 2020.